Biotalys to Publish 2025 Results on March 27 with Live Conference
Biotalys, an agricultural biotechnology company listed on Euronext, announces the release of its annual report and consolidated financial results for the fiscal year 2025 on March 27, 2026. The management will simultaneously hold a conference call and a webcast open to investors.
Biotalys will release its annual report and consolidated financial results for the year 2025 on Friday, March 27, 2026, at 07:00 CET. This announcement comes from a company specializing in the development of protein-based biocontrol solutions for sustainable crop protection. Along with the results publication, the management of the Ghent-based company in Belgium will hold a conference call and a live webcast, followed by a Q&A session in English. This event will take place on the same day, Friday, March 27, 2026, at 15:00 CET, which is 14:00 GMT or 09:00 AM ET. The video broadcast will remain accessible after the event on Biotalys' investor site.
Webcast and Conference Call Details
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The webcast can be accessed via a public streaming link provided. Investors wishing to ask direct questions to the management will need to register in advance for the conference call using the registration form provided. A recording of the presentation will be kept on the group's dedicated financial information platform, available for viewing at any time after the event.
Innovative Biocontrol Solutions
Biotalys develops precision biocontrol solutions based on proteins for crop protection in both pre and post-harvest markets. Founded in 2013 as a spin-off from the Flemish Institute for Biotechnology (VIB), the company has a proprietary technology platform named AGROBODY™ that enables it to design product candidates aimed at addressing major pests and diseases throughout the value chain. Biotalys is listed on the Euronext Brussels and is located in the biotechnology hub of Ghent, Belgium.
Related
SectorProduits Chimiques›Engrais
Context
Period
Period: 2025
Guidance from the release
En 2025, nous avons atteint un point d'inflexion majeur avec l'approbation de notre premier biocontrole.
Nous renforçons notre concentration sur les programmes de biofongicides les plus avancés.
Risks mentioned
Biotalys n'a pas suffisamment de fonds de roulement pour couvrir ses besoins pendant au moins 12 mois.
La société a seulement une visibilité de trésorerie jusqu'à fin mai 2026.
Opportunities identified
Partenariat stratégique avec AgroFresh pour le marché post-récolte.
Développement de programmes avancés de biofongicides.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
